TTM
86.3%
YoY change
−1.08pp
Trough year (2001)
76.3%
Peak year (1992)
173.7%
Latest annual
85.0%
Gross Margin history chart for Vertex Pharmaceuticals (VRTX) from 1991 to 2025
Latest: 85.0%
Gross Margin change chart for Vertex Pharmaceuticals (VRTX) from 1991 to 2025
Latest: −1.08pp
Gross Margin history table for Vertex Pharmaceuticals (VRTX) from 1991 to 2025
| 2025 | 85.0% | -1.08pp | ||
| 2024 | 86.1% | -1.10pp | ||
| 2023 | 87.2% | -0.69pp | ||
| 2022 | 87.9% | -0.16pp | ||
| 2021 | 88.1% | -0.07pp | ||
| 2020 | 88.1% | +1.29pp | ||
| 2019 | 86.8% | +0.28pp | ||
| 2018 | 86.6% | -2.38pp | ||
| 2017 | 88.9% | +1.31pp | ||
| 2016 | 87.6% | -0.20pp | ||
| 2015 | 87.8% | -1.65pp | ||
| 2014 | 89.5% | +0.24pp | ||
| 2013 | 89.3% | +7.58pp | ||
| 2012 | 81.7% | -12.62pp | ||
| 2011 | 94.3% | +3.17pp | ||
| 2010 | 91.1% | +5.04pp | ||
| 2009 | 86.1% | -4.98pp | ||
| 2008 | 91.1% | -1.95pp | ||
| 2007 | 93.0% | -1.36pp | ||
| 2006 | 94.4% | +0.65pp | ||
| 2005 | 93.7% | -0.78pp | ||
| 2004 | 94.5% | -0.98pp | ||
| 2003 | 95.5% | +13.04pp | ||
| 2002 | 82.4% | +6.10pp | ||
| 2001 | 76.3% | -18.44pp | ||
| 2000 | 94.8% | -10.74pp | ||
| 1999 | 105.5% | -4.62pp | ||
| 1998 | 110.1% | +1.92pp | ||
| 1997 | 108.2% | -15.84pp | ||
| 1996 | 124.1% | +7.32pp | ||
| 1995 | 116.7% | -1.12pp | ||
| 1994 | 117.9% | +3.88pp | ||
| 1993 | 114.0% | -59.71pp | ||
| 1992 | 173.7% | +17.43pp | ||
| 1991 | 156.3% | — |
- 202585.0%-1.08pp
- 202486.1%-1.10pp
- 202387.2%-0.69pp
- 202287.9%-0.16pp
- 202188.1%-0.07pp
- 202088.1%+1.29pp
- 201986.8%+0.28pp
- 201886.6%-2.38pp
- 201788.9%+1.31pp
- 201687.6%-0.20pp
- 201587.8%-1.65pp
- 201489.5%+0.24pp
- 201389.3%+7.58pp
- 201281.7%-12.62pp
- 201194.3%+3.17pp
- 201091.1%+5.04pp
- 200986.1%-4.98pp
- 200891.1%-1.95pp
- 200793.0%-1.36pp
- 200694.4%+0.65pp
- 200593.7%-0.78pp
- 200494.5%-0.98pp
- 200395.5%+13.04pp
- 200282.4%+6.10pp
- 200176.3%-18.44pp
- 200094.8%-10.74pp
- 1999105.5%-4.62pp
- 1998110.1%+1.92pp
- 1997108.2%-15.84pp
- 1996124.1%+7.32pp
- 1995116.7%-1.12pp
- 1994117.9%+3.88pp
- 1993114.0%-59.71pp
- 1992173.7%+17.43pp
- 1991156.3%—
Gross Margin values are taken from Vertex Pharmaceuticals's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Margin at Vertex Pharmaceuticals (VRTX)
According to Vertex Pharmaceuticals's latest reported financial statements, the company's latest reported gross margin is 86.3%. Gross margin is gross profit divided by revenue, expressed as a percentage. It shows how much of each sales dollar survives the direct cost of goods sold — before operating expenses, interest, and taxes. A higher gross margin generally signals pricing power and production efficiency. Margins are most meaningful compared against sector peers and a company's own history.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual gross margin for Vertex Pharmaceuticals (VRTX) came in at 85.03% – contracted 1.1 percentage points year-over-year.
173.68% stands as the all-time-high annual gross margin, posted in 1992, against a low of 76.34% during 2001.
Vertex Pharmaceuticals Gross Margin by Year
Vertex Pharmaceuticals Gross Margin 2025: 85.0%
Vertex Pharmaceuticals gross margin in 2025 was 85.03%, contracted 1.1 percentage points from 2024.
Vertex Pharmaceuticals Gross Margin 2024: 86.1%
2024's gross margin for Vertex Pharmaceuticals came in at 86.11%, contracted 1.1 percentage points from 2023.
Vertex Pharmaceuticals Gross Margin 2023: 87.2%
Vertex Pharmaceuticals posted gross margin of 87.21% in 2023, contracted 0.7 percentage points from 2022.
Vertex Pharmaceuticals Gross Margin 2022: 87.9%
In 2022, Vertex Pharmaceuticals reported gross margin of 87.90%, contracted 0.2 percentage points from 2021.
Vertex Pharmaceuticals Gross Margin 2021: 88.1%
Vertex Pharmaceuticals gross margin in 2021 was 88.06%.
See more financial history for Vertex Pharmaceuticals (VRTX).
Sector peers by Gross Margin
Healthcare peers of Vertex Pharmaceuticals (VRTX), ranked by their latest gross margin
| 83.5% | |
| 81.8% | |
| 81.7% | |
| 75.9% | |
| 71.5% | |
| 70.7% | |
| 70.0% | |
| 18.8% |
- 83.5%
- 81.8%
- 81.7%
- 75.9%
- 71.5%
- 70.7%
Frequently asked questions
Vertex Pharmaceuticals (VRTX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation